Organization (Academic)
Beirut Arab University
ClinicalTrials.gov lists Beirut Arab University as lead sponsor of 16 trials. It has 2 active development programs and 4 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 4 registered with a 2026 start date. The dashed outline is the pace from the 4 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo CosmicAnatomy, via Wikimedia Commons, CC BY-SA 4.0. Shown to identify the organization; it may be a registered trademark.
This page covers Beirut Arab University: 16 lead-sponsored trials and 1 legal-entity registration.
Disease areas (16)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 3 |
| Agnosia | 1 |
| Anxiety Disorders | 1 |
| Cancer Pain | 1 |
| Dental Caries | 1 |
Showing 5 of 16 disease areas.
Trials by start year as sponsor or collaborator (6)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 4 |
| 2025 | 5 |
| 2023 | 5 |
| 2022 | 3 |
| 2021 | 1 |
| 2018 | 2 |
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (2)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Gengigel | Gingival Hyperplasia | Early 1 | 1 |
| Gengigel | Gingival Overgrowth | Early 1 | 1 |
Approved assets (4)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| ART: Atraumatic restorative treatment, SMART: Silver-Modified Atraumatic Restorative Treatment | 1 |
| 2.5% flurbiprofen | 1 |
| 98% aloe vera | 1 |
| HYALURONIC ACID | 1 |
Journals published in (79)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of periodontology | 6 |
| International journal of molecular sciences | 4 |
| Journal of Indian Society of Periodontology | 3 |
| Journal of endodontics | 3 |
| Journal of physical therapy science | 3 |
Showing 5 of 79 journals.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 1 | 2005-05-23 |
Organization relationships (2)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Hammoud Hospital University Medical Center | Co sponsors trial with | 1 |
| Bahaa Bou Dargham | Co sponsors trial with | 1 |
Latest dated events (21)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-26 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-01-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-11-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 21 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| FGG | Trial sponsor | Named in trial inclusion criteria |
| FGG | Trial sponsor | Mentioned in trial text |
Biomarkers this organization publishes on (45)
Shown in this order: most publications first.
Showing 5 of 45 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.